Skip to content

Expanding coverage of HIV therapy is highly cost-effective, and could prevent many new infections

Atazanavir for children approved in European Union

Kidney disease increases mortality for women with AIDS starting HIV treatment

Inflammation associated with increased mortality risk for patients with HIV, even when CD4 cell count high

Cotrimoxazole cuts mortality for symptomatic patients with HIV in areas with low malaria prevalence

Good early increases in CD4 count reduce mortality risk for malnourished HIV patients

Will a long life be a good one?

Once-a-day pills and other sticky problems

Viral load increases in cells predicts CD4 cell decline in asymptomatic patients